Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ribotek Biopharmaceuticals (shandong) Co., Ltd

Clinical trials sponsored by Ribotek Biopharmaceuticals (shandong) Co., Ltd, explained in plain language.

Trials to join now! 1

New drug RBD5044 aims to lower high triglycerides in phase 2 trial

Disease control Recruiting now

This Phase 2 trial tests whether the drug RBD5044 can safely lower high triglyceride levels in adults. About 40 Chinese participants with high triglycerides will receive either RBD5044 or a placebo twice over 84 days. The main goal is to see if RBD5044 reduces triglyceride levels…

Phase: PHASE2 • Sponsor: Ribotek Biopharmaceuticals (Shandong) Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC